Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessAuthor Correction: A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection
-
Article
Open AccessA synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection
SARS-CoV-2, the causative agent of COVID-191, features a receptor-binding domain (RBD) for binding to the host cell ACE2 protein1–6. Neutralizing antibodies that block RBD-ACE2 interaction are candidates for the ...